Abiomed
ABMD
#1068
Rank
S$23.56 B
Marketcap
$522.53
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Categories
Abiomed is an American medical devices company that develops and manufactures the circulatory support device Impella, the worldโ€™s smallest heart pump.

Revenue for Abiomed (ABMD)

Revenue in 2022 (TTM): S$1.48 Billion

According to Abiomed's latest financial reports the company's current revenue (TTM ) is S$1.47 Billion. In 2021 the company made a revenue of S$1.35 Billion an increase over the revenue in the year 2020 that were of S$1.07 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Abiomed from 2013 to 2022

20162019$0.5B$1B$1.5Bcompaniesmarketcap.com

Annual revenue

Year Revenue Change
2022 (TTM) S$1.48 B9.47%
2021 S$1.35 B26.1%
2020 S$1.07 B-5.18%
2019 S$1.13 B12.68%
2018 S$1.00 B38.34%
2017 S$0.72 B21.26%
2016 S$0.60 B39.93%
2015 S$0.42 B52.22%
2014 S$0.28 B25.69%
2013 S$0.22 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
S$4.14 B 181.71%๐Ÿ‡บ๐Ÿ‡ธ USA
S$21.81 B 1,381.25%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.61 B-58.33%๐Ÿ‡บ๐Ÿ‡ธ USA